Thermo Fisher Scientific TMO

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$11.67 (-2.48%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Thermo Fisher Scientific (TMO) Business Model and Operations Summary
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).

Key Insights

Thermo Fisher Scientific (TMO) Core Market Data and Business Metrics
  • Latest Closing Price

    $470.03
  • Market Cap

    $177.32 Billion
  • Price-Earnings Ratio

    28.43
  • Total Outstanding Shares

    377.26 Million Shares
  • Total Employees

    125,000
  • Dividend

    $0.43 Per Share Quarterly
  • IPO Date

    August 27, 1980
  • SIC Description

    Measuring & Controlling Devices, Nec
  • Primary Exchange

    New York Stock Exchange
  • Headquarters

    168 Third Avenue, Waltham, MA, 02451

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Short Interest

Short Interest

This information is bi-monthly aggregated short interest data reported to the Financial Industry Regulatory Authority (FINRA) by broker-dealers.

Short Interest: The total number of shares that have been sold short but have not yet been covered or closed out.

Bi-Weekly Change (%): The percentage change in short interest from the previous bi-weekly period.

Settlement Date: The date on which the short interest data is considered settled, typically based on exchange reporting schedules.

Days to Cover: The estimated number of days it would take to cover all short positions based on average trading volume.

Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Short InterestBi-Weekly Change (%)Settlement DateDays to Cover
4,266,587 Shares+2.86%3/14/20252.23
4,147,842 Shares+7.56%2/28/20252.21
3,856,421 Shares-2.32%2/14/20251.91
3,947,987 Shares+13.95%1/31/20251.92
3,464,629 Shares-1.58%1/15/20251.59
3,520,153 Shares-11.03%12/31/20242.15

Cash Flow Statement

January 1, 2024 to December 31, 2024
MetricValue
Net Cash Flow From Financing Activities$-6.79 Billion
Net Cash Flow From Investing Activities, Continuing$-5.84 Billion
Net Cash Flow From Investing Activities$-5.84 Billion
Net Cash Flow From Operating Activities, Continuing$8.67 Billion
Net Cash Flow$-3.97 Billion
Net Cash Flow, Continuing$-3.97 Billion

Income Statement

January 1, 2024 to December 31, 2024
MetricValue
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0
Net Income/Loss Available To Common Stockholders, Basic$6.33 Billion
Benefits Costs and Expenses$35.84 Billion
Revenues$42.88 Billion
Diluted Earnings Per Share$16.53
Other Operating Expenses$25.56 Billion

Comprehensive Income

January 1, 2024 to December 31, 2024
MetricValue
Comprehensive Income/Loss$6.86 Billion
Comprehensive Income/Loss Attributable To Parent$6.86 Billion
Other Comprehensive Income/Loss$520 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$-4 Million

Balance Sheet

January 1, 2024 to December 31, 2024
MetricValue
Long-term Debt$31.07 Billion
Current Liabilities$13.33 Billion
Redeemable Noncontrolling Interest$120 Million
Noncurrent Liabilities$34.44 Billion
Wages$1.99 Billion
Other Current Liabilities$8.27 Billion

Historical Dividends

Current dividend: $0.43 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Feb 19, 2025Apr 15, 2025Mar 14, 2025$0.43Quarterly
Nov 7, 2024Jan 15, 2025Dec 13, 2024$0.39Quarterly
Jul 11, 2024Oct 15, 2024Sep 13, 2024$0.39Quarterly
May 22, 2024Jul 15, 2024Jun 14, 2024$0.39Quarterly
Feb 21, 2024Apr 15, 2024Mar 15, 2024$0.39Quarterly
Nov 9, 2023Jan 16, 2024Dec 15, 2023$0.35Quarterly

Recent Headlines From The Web

Latest news, press releases, and media coverage about TMO from trusted financial sources

    Related Companies

    Publicly traded companies similar to Thermo Fisher Scientific (TMO)